Award notice
Olopatadine HCL 0.1% Ophthalmic Solution
SPE2D222R0117
Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.
Awarded
Golden State Medical Supply, Inc.
$17,621,453.20 on the award notice, February 15, 2023, contract SPE2D223D0007
Get the next one like this from Defense Logistics Agency by email, the day it is posted.Find my opportunities
This one was awarded in 2026
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 5 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 11 daysNov 12
Description
As published on SAM.gov.
Modification SPE2D223D0007 P00013 No-Cost Settlement Termination for Convenience.
Modification SPE2D223D0007 P00012 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).
Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle.
Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23.
Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027.
Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026.
Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract.
Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025.
Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract.
Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract.
Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023.
Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Signed Award SPE2D2-23-D-0007 Olopatadine HCL 0.1% Ophthalmic Solution.pdf807 KB, February 15, 2023
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Golden State Medical Supply, Inc.
- UEI
- GQLDJJ8AQNN5
- CAGE
- 1HT23
- Vendor location
- Camarillo, CA
- Contract
- SPE2D223D0007
- Obligated
- $0.00, potential $17,621,453
- Actions
- 5 between January 26, 2024 and January 27, 2026
- Competition
- Full and Open Competition, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 4610098762!pharm Manuf/Distr Div - FSA
- Match
- award number SPE2D223D0007 equals the contract number; same awarding office SPE2D2 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
January 26, 2024
Award notice
Awarded to GOLDEN STATE MEDICAL SUPPLY Inc. Camarillo for $17,621,453. SAM.gov, notice de044b816b9742959497ad68baeb127a
January 21, 2025
Award notice
Awarded to GOLDEN STATE MEDICAL SUPPLY Inc. Camarillo for $17,621,453. SAM.gov, notice 0d9911fb737e47f1a2aea39f9715757f
January 27, 2026
Award notice
Awarded to Golden State Medical Supply Inc. for $17,621,453. SAM.gov, notice 172ef8534f7745e6b7958d9ad2800173
9 revisions on SAM
- September 24, 2026: publish, award notice
- May 4, 2026: publish, award notice
- January 27, 2026: publish, award notice
- January 21, 2025: publish, award notice
- January 26, 2024: publish, award notice
- August 24, 2023: publish, award notice
- February 22, 2023: publish, award notice
- February 15, 2023: publish, award notice
- June 21, 2022: publish, solicitation
May 4, 2026
Award notice
Awarded to Golden State Medical Supply Inc. for $17,621,453. SAM.gov, notice bbf974a01ba842b69164b07632c5377e
9 revisions on SAM
- September 24, 2026: publish, award notice
- May 4, 2026: publish, award notice
- January 27, 2026: publish, award notice
- January 21, 2025: publish, award notice
- January 26, 2024: publish, award notice
- August 24, 2023: publish, award notice
- February 22, 2023: publish, award notice
- February 15, 2023: publish, award notice
- June 21, 2022: publish, solicitation
September 24, 2026
Award notice
Awarded to Golden State Medical Supply Inc. for $17,621,453. SAM.gov, notice df6c2375129a40959545546683d370c4
9 revisions on SAM
- September 24, 2026: publish, award notice
- May 4, 2026: publish, award notice
- January 27, 2026: publish, award notice
- January 21, 2025: publish, award notice
- January 26, 2024: publish, award notice
- August 24, 2023: publish, award notice
- February 22, 2023: publish, award notice
- February 15, 2023: publish, award notice
- June 21, 2022: publish, solicitation
Points of contact
- Kyle Lewickikyle.lewicki@dla.mil4457370977
- Jason WrayJason.wray@dla.mil4457376304